Literature DB >> 2718741

Disability profiles and objective quantitative assessment in Parkinson's disease.

B Johnels1, P E Ingvarsson, M Thorselius, M Valls, G Steg.   

Abstract

A new technique for quick objective and quantitative determination of important aspects of the motor handicap in movement disorders is presented. A compound, but natural, test movement was used to find out if the degree of dysfunction in postural, locomotor and manual motor functions differed among the patients and if medication influenced these functions differently. After 12 h without medication, 16 patients with Parkinson's disease showed a movement time between 1.5 and 13.6 times that of an age-matched normal subject and a greater performance variability on repeated examination. In some patients the increase of test movement time was caused mainly by the locomotion component while in others the time for the postural or manual part of the movement was more markedly augmented. Thus, a specific motor disability profile was found for each patient and expressed in quantitative terms. The effects of l-dopa treatment were quantified in each patient.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2718741     DOI: 10.1111/j.1600-0404.1989.tb03743.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  8 in total

1.  Portable, Non-Invasive Fall Risk Assessment in End Stage Renal Disease Patients on Hemodialysis.

Authors:  Thurmon E Lockhart; Adam T Barth; Xiaoyue Zhang; Rahul Songra; Emaad Abdel-Rahman; John Lach
Journal:  ACM Trans Comput Hum Interact       Date:  2010       Impact factor: 2.351

2.  Gait quantitation in Parkinson's disease--locomotor disability and correlation to clinical rating scales.

Authors:  P Vieregge; H Stolze; C Klein; I Heberlein
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Usefulness of pallidotomy in advanced Parkinson's disease.

Authors:  F Johansson; J Malm; E Nordh; M Hariz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

4.  Intraduodenal infusion of a water-based levodopa dispersion for optimisation of the therapeutic effect in severe Parkinson's disease.

Authors:  E Bredberg; D Nilsson; K Johansson; S M Aquilonius; B Johnels; C Nyström; L Paalzow
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 5.  Physiological mechanisms and movement analysis in Parkinson's disease.

Authors:  G Steg; B Johnels
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

6.  Levodopa induced ON-OFF motor fluctuations in Parkinson's disease related to rhythmical masticatory jaw movements.

Authors:  S Karlsson; M Persson; B Johnels
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

7.  Evaluation of the objective posturo-locomotor-manual method in patients with parkinsonian syndromes.

Authors:  Theresa Zackrisson; Filip Bergquist; Björn Holmberg; Bo Johnels; Thorleif Thorlin
Journal:  Front Neurol       Date:  2013-07-19       Impact factor: 4.003

8.  Better Outcomes with Intranigral versus Intrastriatal Cell Transplantation: Relevance for Parkinson's Disease.

Authors:  Marine Droguerre; Sébastien Brot; Clément Vitrac; Marianne Benoit-Marand; Laure Belnoue; Maelig Patrigeon; Anaïs Lainé; Emile Béré; Mohamed Jaber; Afsaneh Gaillard
Journal:  Cells       Date:  2022-04-01       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.